MRg-NIRS Imaging System Breast Cancer Trial

Description

This trial is a study of 20 women with breast cancer to evaluate the addition of MR-guided (MRg) near-infrared spectroscopy (NIRS) with and without contrast, as part of a program to improve clinical management of women receiving breast magnetic resonance imaging (MRI).

Conditions

Breast Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

This trial is a study of 20 women with breast cancer to evaluate the addition of MR-guided (MRg) near-infrared spectroscopy (NIRS) with and without contrast, as part of a program to improve clinical management of women receiving breast magnetic resonance imaging (MRI).

Evaluation of the Magnetic Resonance-guided (MRg) Near-infrared Spectroscopy (NIRS) Imaging System Platform in Breast Cancer Patients

MRg-NIRS Imaging System Breast Cancer Trial

Condition
Breast Cancer
Intervention / Treatment

-

Contacts and Locations

Lebanon

Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States, 03756

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Females age ≥ 18 years old
  • 2. Participants capable of providing written informed consent
  • 3. Women with a recent diagnosis of breast cancer.
  • 4. Women who are in pre-surgical planning must have an estimated tumor size of 2.0 cm or less on available imaging.
  • 5. Women who are in pre-surgical planning must have had a breast biopsy at least 10 days prior to the MRg-NIRS exam.
  • 1. Participants with absolute or relative contraindication to MRI:
  • 1. the presence of an electronic implant, such as a pacemaker
  • 2. the presence of a metal implant, such as an aneurysm clip
  • 3. claustrophobia
  • 4. renal failure (FDA's guidance for gadolinium of a creatinine clearance less than 30 mL/1.73 m2 BSA)
  • 2. Pregnant women
  • 3. Breast implants
  • 4. Prisoners
  • 5. Participants with visually inadequate healing from breast biopsy.

Ages Eligible for Study

18 Years to 83 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Keith D. Paulsen,

Keith D. Paulsen, PhD, PRINCIPAL_INVESTIGATOR, Dartmouth College

Study Record Dates

2025-03-31